This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Appeals court raises possibility of reviving Adderall agreement case

By Richard Vanderford ( March 17, 2014, 20:48 GMT | Insight) -- ​Federal appeals judges suggested that they could reopen an antitrust case alleging that drug buyers overpaid for Shire's Adderall because the company reneged on an agreement to supply it to its generic competitors, saying that the analysis may have changed in light of the Supreme Court's Actavis decision.Federal appeals judges suggested on Monday that they could reopen an antitrust case alleging that drug buyers overpaid for Shire's Adderall because the company reneged on an agreement to supply it to its generic competitors, saying that the analysis may have changed in light of the Supreme Court's Actavis decision....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections